key: cord-0270021-2opu1ko1
authors: Savage, H. R.; Finch, L.; Body, R.; Watkins, R. L.; LSTM Diagnostics Group,; CONDOR steering group,; Hayward, G.; Cook, E.; Cubas Atienzar, A. I.; Cuevas, L.; MacPherson, P.; Adams, E. R.
title: A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing
date: 2021-12-07
journal: nan
DOI: 10.1101/2021.12.06.21267356
sha: f267c8d04d0af136e869f6acfa843886a7ff7f02
doc_id: 270021
cord_uid: 2opu1ko1

Objectives: To compare self-taken and healthcare worker (HCW)-taken throat/nasal swabs to perform rapid diagnostic tests (RDT) for SARS-CoV-2, and how these compare to RT-PCR. We hypothesised that self-taken samples are non-inferior for use with RDTs and in clinical and research settings could have substantial individual and public health benefit. Design A prospective diagnostic accuracy evaluation as part of the Facilitating Accelerated Clinical Evaluation of Novel Diagnostic Tests for COVID -19 (FALCON C-19), workstream C (undifferentiated community testing). Setting NHS Test and Trace drive-through community PCR testing site (Liverpool, UK). Participants Eligible participants 18 years or older with symptoms of COVID-19. 250 participants recruited; one withdrew before analysis. Sampling Self-administered throat/nasal swab for the Covios RDT, a trained HCW taken throat/nasal sample for PCR and HCW comparison throat/nasal swab for RDT. Main outcome measures Sensitivity, specificity, and positive and negative predictive values (PPV, NPV) were calculated; comparisons between self-taken and HCW-taken samples used McNemars test. Results Seventy-five participants (75/249, 30.1%) were positive by RT-PCR. RDTs with self-taken swabs had a sensitivity of 90.5% (67/74, 95% CI: 83.9-97.2), compared to 78.4% (58/74, 95% CI: 69.0-87.8) for HCW-taken swabs (absolute difference 12.2%, 95% CI: 4.7-19.6, p=0.003). Specificity for self-taken swabs was 99.4% (173/174, 95% CI: 98.3-100.0), versus 98.9% (172/174, 95% CI: 97.3-100.0) for HCW-taken swabs (absolute difference 0.6%, 95% CI: 0.5-1.7, p=0.317). The PPV of self-taken RDTs (98.5%, 67/68, 95% CI: 95.7-100.0) and HCW-taken RDTs (96.7%, 58/60, 95% CI 92.1-100.0) were not significantly different (p=0.262). However, the NPV of self-taken swab RDTs was significantly higher (96.1%, 173/180, 95% CI: 93.2-98.9) than HCW-taken RDTs (91.5%, 172/188, 95% CI 87.5-95.5, p=0.003). Conclusion Self-taken swabs for COVID-19 testing offer substantial individual benefits in terms of convenience, accuracy, and reduced risk of transmitting infection. Our results demonstrate that self-taken throat/nasal samples can be used by lay individuals as part of rapid testing programmes for symptomatic adults. Trial Registration IRAS ID:28422, clinical trial ID: NCT04408170

(220764/Z/20/Z), FALCON C-19 study was funded by National Institute for Health Research (NIHR), Asthma UK and the British Lung Foundation; and is supported by the global alliance for diagnostics (FIND) . ERA contributed to this study design and analysis in her role as PhD supervisor to HRS at LSTM, she is also Director of Epidemics and NTDs at Mologic Ltd a UK diagnostics company who provided the RDTs for this study under joint Wellcome funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Patient and public involvement statement:

The CONDOR platform (COVID-19 National DiagnOstic Research and evaluation platform) has two PPI representatives on its steering committee meeting fortnightly. They contribute to the prioritisation of research within the platform, support and lead on developing new research priorities and co-produce plain language summaries and infographics detailing study findings.

Within the nested FALCON C-19 study at LSTM results will be disseminated to the public within Liverpool by social media statements, press releases and attendance at open science events.

Keywords: Covid-19, diagnosis, self-testing, health worker-taken, Lateral flow assays, adults Word count: Abstract, 325; Manuscript, 2328 Summary:

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint What is already known on this topic?

• Rapid diagnostic tests (RDTs)for SARS-CoV-2 Ag are a cheaper point-of-care alternative to RT-PCR for diagnosing COVID-19 disease.

• The accuracy of tests can vary dependent on sampling technique, test processing and reading of results.

What this study adds?

• Self-taken throat-nasal swabs for RDTs can be used by symptomatic adults to give reliable results to diagnose SARS-CoV-2.

• Self-sampling can be implemented with little training and no assistance.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint

Objectives:

To compare self-taken and healthcare worker (HCW)-taken throat/nasal swabs to perform rapid diagnostic tests (RDT) for SARS-CoV-2, and how these compare to RT-PCR. We hypothesised that self-taken samples are non-inferior for use with RDTs and in clinical and research settings could have substantial individual and public health benefit. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 7, 2021.

The Severe Acute Coronavirus 2 (SARS-CoV-2) is a novel pathogen causing Coronavirus Disease-19 (COVID-19) that emerged in December 2019 and spread quickly around the globe before being declared a pandemic on 20 th March 2020. Confirmation of SARS-CoV-2 infection is recommended by real-time polymerase chain reaction (RT-PCR) testing, however this requires well-resourced laboratory facilities, which are not available in many settings (1) . Given the need to rapidly upscale testing, rapid diagnostic tests (RDTs) were developed to detect SARS-CoV-2 antigen(s) (Ag), which can be used at point of care without a laboratory infrastructure. Guidance from the World Health Organization (WHO) recommends using RDTs in settings with trained health workers to facilitate collecting samples and processing tests (1) . Currently, large-scale self-testing for SARS-CoV-2 is conducted in schools, workplaces, and homes in the U.K.; however concerns have been raised over the accuracy of these tests and the risk of missing infected individuals (2). Many tests designed and regulated for "Professional Use Only" have been implemented for self-testing use, but little accuracy information exists for self-swabbing and interpretation.

Previous work has suggested that RDTs achieve higher sensitivity when performed by laboratory scientists (sensitivity of the Innova lateral flow test 70%, 95% CI 63-76%) than by healthcare workers (sensitivity 79%, 95% CI 72-84%)(3). Sensitivity can be substantially affected by the quality of the sample and swabbing technique (4) . A small number of studies have compared self-taken to healthcare worker (HCW) taken swabs for RT-PCR, with a high degree of concordance (5, 6) . To the best of our knowledge, no studies have compared self-taken and HCW-taken samples with identical swab types and identical RDTs rather than comparing alternative sampling strategies.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint

We therefore set out to compare the sensitivity and specificity of self-taken and HCW-taken throat/nasal swabs to perform a RDT for SARS-CoV-2, and how these sampling approaches perform compared to the RT-PCR. We hypothesised that, if self-taken samples are accurate for use with RDTs in clinical and research settings, this could have substantial individual and public health benefit.

We conducted a prospective diagnostic accuracy evaluation to compare self-taken and HCWtaken throat/nasal swabs RDTs with a standard HCW-taken throat/nasal swab tested using RT-PCR. Participants were recruited as part of the 'Facilitating Accelerated Clinical Evaluation of Novel Diagnostic Tests for COVID -19 (FALCON), workstream C (undifferentiated community testing)'(7), which aims to evaluate the diagnostic accuracy of commercially supplied in-vitro diagnostic (IVD) tests for SARS-CoV-2 infection.

Participants were recruited consecutively when presenting at the Liverpool John Lennon Airport (Liverpool, UK) drive through community PCR testing site, a National Health Service (NHS) Test and Trace site for the general population with symptoms of COVID-19, defined as a high temperature, continuous cough or change in sense of taste or smell. People presenting for testing were assessed for eligibility in their vehicle and received a patient information sheet prior to offer of NHS test. Eligible participants were 18 years or older who verbally confirmed they currently had symptoms of COVID-19. If multiple occupants were in the vehicle, they were each assessed for eligibility. Informed verbal consent was taken and recorded by a researcher on site.

Demographic and symptom data were recorded electronically. We excluded anyone under 18 years, or who did not state they currently had COVID-19 symptoms, or if they did not consent to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint participate. We did not record people who declined to participate. As people presented to the testing centre in vehicles, we were unable to distinguish between drivers or relatives, and people presenting for testing services.

A HCW in personal protective equipment (PPE, in line with local guidelines) passed a selfcollection kit for each participant into the vehicle. Each kit contained a short instruction sheet taken from the manufacturer protocol (see Appendix), a tissue, a swab, and collection tube. The participant self-administered their throat/nasal swab without further advice, observation, or supervision. Once complete the participant signaled the research team and a trained healthcare worker took a throat/nasal sample using a COPAN mini UTM (universal transport medium) kit 1ml for PCR from one side and a comparison swab for RDT from the other. All swabs taken for RDT were randomly numbered so that laboratory staff performing the RDTs were blinded to sample collection method and could not identify paired samples. CALFD-130-1). RDTs were run according to the manufacturer's instructions and read and graded (1-10 from a visual card) by two trained researchers. If there was disagreement between the two readers, a third reader was requested.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint RNA was extracted from batched UTM samples using the QiAamp96 Virus Qiacube HT kit and RT-PCRs were run following manufacturer's instruction using TaqPath COVID-19 RT-PCR on QuantStudio 5 (ThermoFisher). RT-PCR reactions volumes were made in 20 µl. Reverse transcription step was performed at 53°C for 10 minutes and this was followed by an activation step of 2 minutes at 95°C, then PCR was carried for 40 amplification cycles at 95°C for 3 minutes and 60°C for 30 seconds. Fluoresce was recorded in the FAM, VIC, ABY and JUN channels for the ORF1ab, N, S and MS2 targets respectively.

Sample size was calculated using an alpha of 0.05, anticipated prevalence of 20% (based on UK PHE positivity of all PCR tests carried out (10)), minimum test sensitivity of 80%, specificity 99%, and precision interval of 10% (11). These gave a planned sample size of 308. We 

Two hundred and fifty participants were recruited between the 31 st March 2021 and the 9 th August 2021. One participant withdrew after recruitment and did not wish data or samples to be all participants were symptomatic. The median duration since symptom onset was 2 days (IQR 1-3 days).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (Table 2) . HCW-taken RDTs had a sensitivity of 78.4% (58/74, 95% CI 69.0-87.8) and specificity of 98.9% (172/174, 95% CI: 97.3-100.0) compared to the reference standard. The difference in sensitivity was 12.2% (95% CI: 4.7-19.6, p=0.003), the difference in specificity was 0.6% (95% CI: 0.5-1.7, p=0.317). Of the self-HCW RDT pairs, 238/248 (96.0%) agreed, and 10/248 (4.0%) were discordant. Of the discordant pairs, on nine occasions the self-taken swab RDT was read as positive, while the HCW-taken swab was read negative ( Table 3) . Nine of these pairs were RT-PCR positive and one negative. The discordant pair that was RT-PCR negative, the HCW-taken swab RDT was positive, while the self-taken RDT was negative.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. 

This study found that the sensitivity of self-taken swabs for the detection of SARS-CoV-2 antigen was higher (90.5%) than using HCW-taken swabs (78.3%), with similar specificity. No RT-PCR-positive results from HCW-taken swabs were missed by self-taken swabs and the PPV and NPV for both methods were over 90%.

Current WHO guidance for implementing RDTs indicates swabbing to collect samples should be conducted by trained professionals (1). Using self-sampling for testing would reduce the workload of health workers and increase the ability of services to test patients in both clinical and research settings where trained workers are not available. These results show self-taken . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint throat-nasal samples with only written and pictorial instructions can be used by the general public for RDTs and is not likely to reduce the sensitivity of testing, which could widen access.

Within this study, self-taken swabs had higher sensitivity than HCW swabs for RDTs in a general population setting in the UK. The self-swabbing technique was not monitored for quality, no participants failed to take the swabs and no assistance was given so the results could be extrapolated to other non-supervised settings. The high concordance of self-and HCW-taken results has been reported from studies comparing self-and HCW-taken swabs for PCR testing and with also studies looking at alternative swab types (nasopharyngeal, nasal only) for RDTs (6,12-14).

The limitations of this study are that the sampling order was not randomized as the HCW swab for RDT was taken after the swab for the RT-PCR, and only from one nostril; this may lower sensitivity or participants may experience sampling fatigue. However, previous studies have shown that repeated sampling from one nostril does not impact RT-PCR sensitivity or CT values (15). Participation was voluntary so people who were less confident to take their own sample may not have agreed to take part; it is also likely participants may have done previous COVID-19 tests, and so have experience of self-sampling.

By focusing on differences in the sampling process (thus removing issues of running and interpretation of RDTs), we have shown that the sampling quality is unlikely to explain the differences in test accuracy, and that if individuals self-take samples for RDTs, the results can be as accurate as professionally taken swabs. All RDT-positive tests in the UK are currently confirmed with follow-on PCR tests which, given the high prevalence of circulating infection, are unlikely to result in many false positives and the high workloads can lead to laboratory . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint errors. Recent test discrepancies in South-West England, which reported large numbers of RDTpositive but PCR-negative results, were due to incorrect PCR results, with correct RDTs results (16). Our study suggest that the public and healthcare professionals should trust RDT-positive tests from self-taken samples in symptomatic individuals.

In conclusion, self-taken swabs for COVID-19 testing offer substantial individual benefits in terms of convenience, accuracy, and reduced risk of transmitting infection during swabbing. Our results demonstrate that, with no training, self-taken throat/nasal samples can be used by lay individuals as part of rapid testing programmes for symptomatic adults. Self-testing has the potential to widen access to early diagnosis for COVID-19 in clinical services and outreach settings where the lack of trained healthcare workers restricts access to testing.

Tu A box plot comparing self-taken and healthcare worker taken swabs tested by Covios® RDT by mean PCR CT value.

Self-taken and HCW taken Covios® Ag RDT results by RT-PCR CT range.

Covios® leaflet from study . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted December 7, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.06.21267356 doi: medRxiv preprint

SARS-CoV-2 antigen-detecting rapid diagnostic tests -An implementation guide

Covid-19: How the UK is using lateral flow tests in the pandemic

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: Population based cohort study

Assessment of Sensitivity and Specificity of Patient-Collected Lower Nasal Specimens for Sudden Acute Respiratory Syndrome Coronavirus 2 Testing

We acknowledge the support of the National Institute for Health Research (NIHR) ClinicalResearch Network, which supports delivery of the FALCON study. The views expressed in this article are those of the authors and not necessarily those of the NIHR, or the Department of Health and Social Care.